PAYER POLICY CHANGES

J2252 Insurance Policy Changes

HCPCS J2252 is officially defined as "Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg." HCPCS J2252 is referenced in 1 tracked payer policy change from Blue Cross and Blue Shield of Louisiana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J2252 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J2252

Get one email when a payer policy names J2252, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J2252

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J2252 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.